October 13, 2021
by Dylan Scott
Congress’s ambitious plans to expand health coverage are crashing up against one of the great questions in health policy: Can they force the pharmaceutical industry to hold down prescription drug prices without sacrificing the medical innovation that could lead to new treatments and cures in the future?..Demonstrators from People’s Action protest pharmaceutical lobbying against allowing Medicare to negotiate lower prescription drug prices, during a rally on September 21, in Washington, DC.